Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001193805-20-001003)

Filing Details

Accession Number:: 0001193805-20-001003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-12 08:01:42
Reporting Period:: 2020-08-10

Accepted Time:: 2020-08-12 08:01:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368514	Adma Biologics Inc.	ADMA	Biological Products, (No Disgnostic Substances) (2836)	562590442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1554537	James Mond	C/O Adma Biologics, Inc. 465 State Route 17 Ramsey NJ 07446	Evp, Cso And Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-10	5,000	$2.88	67,174	No	4	P	Direct
Common Stock	Acquisiton	2020-08-10	2,000	$2.88	69,174	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 40,000 RSUs granted on February 28, 2020, which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting.